Navigation Links
Verenium Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012
Date:3/27/2013

$
(3,615)$
(2,747)$
8,269$
5,630Adjustments:  Gain on sale of oilseed processing business.

----(31,278)--Restructuring charges

33302,943Income tax (benefit) provision (attributed to sale of oilseed processing business)

(380)(368)226(368)Gain on debt extinguishment upon repurchase of convertible notes

------(15,349)(Gain) loss on net change in fair value of derivative assets and liabilities

 

(19) 

(136)548869Non-GAAP pro forma net loss from continuing operations 

$
(4,011)$
(3,248)$
(12,205)$
(6,275)Non-GAAP pro forma net loss from continuing operations per share, basic 

 

$
(0.31) 

$
(0.26)$
(0.96)$
(0.50)*Financial statements for 2011 have been restated to reflect the impact of revisions to the accounting for the Company's building lease in San Diego, CA, as well as corrections for immaterial audit adjustments that were not recorded in the previously reported numbers. The adjustments resulted in the recording of a long-term building asset and related lease financing liability on the Company's consolidated balance sheets. The impact of all adjustments on the Company's operating results was insignificant. Refer to the Company's Current Report on Form 8-K filed on March 14, 2013 and the Company's Annual Report on Form 10-K to be filed on or before April 1, 2013 for more information.


'/>"/>
SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Verenium Announces Preliminary Financial Results For Fiscal 2012
2. Verenium To Present At The 25Th Annual Roth Conference
3. Verenium Appoints Holger Liepmann To Its Board Of Directors
4. Verenium To Sponsor The Renewable Fuels Association 18th Annual National Ethanol Conference
5. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
6. Verenium Announces $22.5 Million, Five-Year Secured Financing
7. Verenium Corporation To Announce Third Quarter 2012 Financial Results
8. Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
9. Verenium Corporation To Announce Second Quarter 2012 Financial Results
10. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing
11. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... (PRWEB) October 02, 2014 Protea ... AG jointly announced today an update from their ... 3D InSight™ microtissues. In August 2014, Protea received ... scientific team for onsite training on the handling ... developed workflows for processing the 3D microtissues for ...
(Date:10/2/2014)... Wayne, NJ (PRWEB) October 02, 2014 At ... squeezed, Bel-Art Products has introduced a new kind ... New to market is the Scienceware® Squeeze Rite™ Wash ... the dip tube position within the bottle reduces the waste ... complete dispensing of those liquids. , “Easier to squeeze when ...
(Date:10/2/2014)... 2, 2014  CSSi ( www.CSSiEnroll.com ), the ... research industry, is pleased to announce its participation ... of October.  President Chris Trizna will ... in Clinical Trials New England conference sponsored by ... the annual Site Solutions Summit sponsored by the ...
(Date:10/2/2014)... and BRIDGEWATER, N.J. , Oct. 2, ... a leader in synthetic biology, and Amneal ... manufacturer by volume in the U.S., today announced ... (ECC) for a target active pharmaceutical ingredient (API).  ... of the collaboration is to develop a consistent, ...
Breaking Biology Technology:Protea Biosciences and InSphero AG Successful in Mass Spectrometry Imaging of 3D Microtissues 2Protea Biosciences and InSphero AG Successful in Mass Spectrometry Imaging of 3D Microtissues 3Protea Biosciences and InSphero AG Successful in Mass Spectrometry Imaging of 3D Microtissues 4New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 2Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 3Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3
... Aug. 28 Medivation, Inc.,(Nasdaq: MDVN ) today ... will present at the following conferences:, -- BioCentury,s ... 9:00 a.m. Eastern Time at the Millennium Broadway Hotel ... Conference on Wednesday, September 24,at 4:30 p.m. Eastern Time ...
... Exclusion of Venous Thromboembolism-, LEXINGTON, Mass., Aug. ... US Food and Drug Administration (FDA) has,granted 510(k) ... HemosIL D-Dimer,assay to exclude venous thromboembolism (VTE) in ... embolism (PE), when used in,conjunction with a clinical ...
... (ESA) has appointed the UK,s National Physical Laboratory (NPL) ... will lead a consortium to identify the next generation ... in future space missions. , "Advances in nanotechnology are ... Research Scientist in the nanomaterials group at NPL, who ...
Cached Biology Technology:Medivation Announces Participation in Upcoming Conferences 2Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay 2
(Date:9/30/2014)... captured the popular attention of both children and aquarium ... sold as dehydrated eggs, these tiny brine shrimp readily ... tank of salt water. , Physicists, though, are ... shrimp vertically migrate in large groups in response to ... night and retreating deeper during the day. , Two ...
(Date:9/30/2014)... Prenatal exposure to tetrachloroethylene (PCE) in drinking water ... abruption, according to a new study led by ... , The study, published in the journal ... 1,019 unexposed pregnancies among 1,766 women in Cape ... late 1960s to the early 1980s by the ...
(Date:9/30/2014)... runoff in Hawaii is causing tumors in endangered sea ... published Tuesday in the peer-reviewed open-access journal PeerJ ... in algae that the turtles eat, promoting the formation ... organs. , Scientists at Duke University, the University of ... conducted the study to better understand the causes ...
Breaking Biology News(10 mins):Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Contaminated water linked to pregnancy complications, BU study finds 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3
... Autism Speaks applauds the consensus statement and recommendations ... disorders in children with autism spectrum disorders (ASD) released ... advancing physician awareness of unique challenges in the medical ... see the publication of these consensus recommendations. Autism Speaks, ...
... nerves are the likely origin of the Devil Facial Tumour ... an international team of scientists has discovered. Devil ... only Tasmanian devils and was first reported in 1996. It ... disease is characterised by large tumours, mostly on the face ...
... have new insight into the sex lives of the much-maligned ... deaths, according to a report published online on December 31st ... finding a partner of the right species type, male and ... harmony. Those tones are produced and varied based on the ...
Cached Biology News:Pediatrics GI recommendations -- first step to guidelines for children with autism 2Pediatrics GI recommendations -- first step to guidelines for children with autism 3Nervous culprit found for Tassie devil facial tumor disease 2To a mosquito, matchmaking means 'singing' in perfect harmony 2
Melanoma Antigen, Family C, 1 (MAGEC1) Rabbit anti-Human Polyclonal Antibody Immunogen: Synthetic peptide - KLH conjugated Family: New Recommended Storage: Long term: -20C; Short term: +4...
X box-binding protein 1...
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
Mouse HAI-1 Ectodomain MAb (Clone 199732)...
Biology Products: